Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of death and second leading cause of disability in the United States, is one of our division's major areas of research.
We are strongly committed to investigating COPD. With our ongoing research, we strive to improve treatment and facilitate the prevention of this widespread, serious illness.
Patients followed at this facility receive state-of-the-art care from internationally recognized physicians. By collecting specimens from patients over time and following patients' progress, we study the natural history of COPD and identify the mechanisms that lead to clinical deterioration.
At this facility, we work with dedicated equipment to measure lung function by spirometry and perform sputum induction. The clinical focus of our COPD research is to develop new therapeutics and examine the effects of current treatments on host-pathogen interactions in COPD.
The scope of research at this unit includes basic, translational and clinical research. We are supported by investigator-initiated grants and federal funds such as the National Heart, Lung and Blood Institute and the U.S. Department of Veterans Affairs.
Our clinical studies unit also determines which patients can be enrolled in clinical studies aimed at identifying new ways to treat COPD.
We collaborate with the Division of Infectious Diseases at this unit, giving you experience working with faculty from a variety of backgrounds.
Eighth floor, B wing
Buffalo VA Medical Center